Abstract:AIM:To investigate the bioequiavailability of the two kinds of pidotimod oral solution (Fulu-Yin and Polimod),which produced by Jiangsu Wuzhong Pharmaceutical Group Co.,Ltd and Italy Duopa pharmaceutical company,respectively,and to explore the influence of dosage forms on bioavailability of pidotimod via comparing the pharmacokinetics and relative bioavailability of pidotimod tablet,granules,capsules and dispersible tablets in beagle dogs.METHODS:Beagle dogs were orally administrated 400 mg of pidotimod oral solution Fulu-Yin and Polimod and the four kinds pidotimod solid preparations,respectively.After quantitatively measuring the concentrations of pidotimod in plasma,the pharmacokinetic parameters and relative bioavailability of Polimod,pidotimod tablet,granules,capsules and dispersible tablets were calculated and compared with those of Fulu-Yin to investigate the bioequiavailability of different dosage forms of pidotimod.RESULTS:The pharmacokinetic parameters of the pidotimod after ig administration of 400 mg of Fulu-Yin were as follows:t1/2 was (3.88 ± 0.77) h,Cmax was (23 367 ± 5 298) ng/mL,TmaxWas (1.1 ±0.5) h,AUC0-τ was (93948 ± 28 016) ng · h · mL-1.The pharmacokinetic parameters of the pidotimod after ig administration of 400 mg of Polimod were as follows:t1/2 was (3.50 ± 0.36) h,Cmax was (21233 ± 5542) ng/mL,AUC0-τ was (83 032 ±20 539) ng · h · mL-1.Besides,the pharmacokinetic parameters the pidotimod have no significant difference after ig administration of 400 mg of pidotimod tablet,granules,capsulesand dispersible tablets.CONCLUSION:The pharmaceutical Fulu-Yin and Polimod were bioequivalent in Beagle dogs,and the pidotimod oral liquid had higher bioavailability than pidotimod tablet,granules,capsules and dispersible tablets.

A Comparison Study of Main Pharmacokinetic Parameters on Pridinol Mesylate Orally Disintegrating Tablets and Conventional Tablets in Beagle Dogs

Study on Preparation of Levetiracetam Sodium Extended-release Tablet and It's Pharmacokinetics in Beagle Dogs

Study on Pharmacokinetics of Melatonin Orally Disintegrating Tablets and Common Tablets in Beagle Dogs

Pharmacokinetics and bioavailability of pidotimod in Beagle dog after oral solution and different solid preparations

Pharmacokinetics of Melatonin Sustained Release Tablets and Common Tablets in Beagle Dogs

A Pharmacokinetic Study on Carteolol Hydrochloride Matrix Sustained-release Pellets in Beagle Dogs

Pharmacokinetics of Propafenone Hydrochloride Sustained-Release Capsules in Male Beagle Dogs

Study on the Bioavailability and Pharmacokinetics of Guaiphenesin Sustained Release Tablets in Beagle Dogs

Pharmacokinetic behavior and relative bioavailability of propylthiouracil sustained-release tablets vs market tablets in dogs

Study on Pharmacokinetics-Pharmacodynamics of Xinning Extended Action Tablet on Dogs

Pharmacokinetics of piroxicam-β-cyclodextrin inclusion complexes in Beagle dogs

The study of pharmacokinetics of metoprolol succinate sustained release tablets in dogs

Pharmacokinetics and Relative Bioavailability of Sustained-Release Alfzosin Hydrochloride Capsules in Healthy Beagle Dogs

Oral Pharmacokinetic Comparison of Different Genistein Tablets in Beagle Dogs

Study on in Vivo Pharmacokinetics and Relative Bioavailability of Cefprozil Dispersible Tablet in Beagle Dogs

Pharmacokinetics and bioequivalence of Nifedipine Sustained-release Pellets in Bea-gle dogs

Effect of N-trimethyl Chitosan on the Pharmacokinetic Parameters of Nifedipine Tablets in Beagle Dogs

Bioequivalence and Pharmacokinetic Characteristics of Lovastatin Sustained Release Tablets in Beagle Dogs

Study on Pharmacokinetics Compound Niacin Extended-release Tablets in Beagle Dogs

Bioequivalence and pharmacokinetics characteristics of clozapine sustained release tablets in Beagle dogs

Pharmacokinetics of Oral Administration of 2, 3, 5, 4'-Tetrahydroxystilbene-2-o-β-d-glucoside from Polygonum Multiflorum in Beagle Dogs